![]() For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn, Facebook, and Instagram. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad global network of hospitals, academic centers, laboratories and biopharma institutions. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native software company in the healthcare space dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. Through the use of SOPHiA GENETICS’ technology, the new assay from Acutis Diagnostics is expected to further clinical research and treatments for those who encounter hereditary cancers.įor more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn, Facebook, and Instagram. This technology enables clinical researchers to accurately characterize the complex mutational landscape associated with major hereditary cancer disorders. The SOPHiA GENETICS hereditary cancer solutions are NGS-based applications that use artificial intelligence and machine learning with patented technologies to analyze raw NGS data and provide simplified insights. 1 Next-generation sequencing (NGS) is the technology of choice in detecting biomarkers for hereditary cancers and identifying mutations that help to inform treatment options. “The new assay from Acutis Diagnostics will be designed to enable clinical researchers to work faster, and with a sound set of insights around their data, ultimately benefitting their current and future patients, as well as the industry as a whole.”Īn estimated 20% of cancer patients have a family history of cancer. “Our work at SOPHiA GENETICS is focused on creating technology and solutions that make it easier for everyone to practice and benefit from data-driven medicine,” said Ken Freedman, Chief Revenue Officer, SOPHiA GENETICS. “Additionally, the test is to provide researchers with a robust set of data and insights to support clinical decision-making and future research.” Abdel Halim, Chief Scientific Officer and Executive Vice President, Acutis Diagnostics. “The use of SOPHiA DDM™ will help us quickly launch this new assay to aid clinical researchers in speeding up the process for launching select clinical oncology trials and ensuring the most appropriate patients are enrolled,” said Dr. ![]() The test is in support of genomic screening for patient enrollment in oncology clinical trials and for retrospective analyses to help explain clinical outcomes and drug target discovery. To create the new assay, Acutis Diagnostics will pair SOPHiA DDM™ for Hereditary Cancers Solution with their laboratory analysis technologies. This new next-generation sequencing (NGS) test will build on Acutis Diagnostics’ track record of approved lab-developed tests that support clinical trials, cancer research and treatment. ![]() Letters and test results can only be printed from a desktop device.BOSTON & LAUSANNE, Switzerland-( BUSINESS WIRE)-SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Acutis Diagnostics, a specialized medical laboratory, will use SOPHiA DDM™ to develop a new genomic assay. Via Healow app: To view labs, click My Records on the wheel and then Results on the next screen. To view lab results a second or third time, click Medical Records on the left side of the portal and choose Lab/Diagnostic Reports. Via Desktop: New labs will show on the patient’s dashboard/home screen. If you cannot remember your password after setting up your account, click on the “trouble logging in” button on the portal homepage to recover the portal. When prompted, use our practice code: HAFHBD. Your test results will NOT be available on PM Pediatric Care TelemedicineĪfter completing account setup, you can access the portal by visiting and clicking the Patient Portal button on the homepage, or by downloading the Healow app to login. IMPORTANT: The patient portal is different from your PM Pediatric Care Telemedicine account. You must set up your patient portal in order to view your test results. The email subject line will be “Portal login information from your doctor’s office.” If you don’t see the email, check your spam/junk folder. You will need your phone number and the patient’s date of birth to complete the setup and it must match the information provided for the patient’s chart. ![]() Please note that the username will be unique for each patient. On the same day of your visit to our office, please check your inbox for an email from “PM Urgent Care Patient Portal'' that includes your username, a link to the portal, and setup instructions. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |